HOME >> MEDICINE >> NEWS
Second patient with multiple sclerosis undergoes groundbreaking surgery at Yale

New Haven, Conn. A 29-year-old man with multiple sclerosis is the second patient to undergo transplantation surgery at Yale in an effort to repair myelin, the protective brain and spinal cord sheath that is destroyed by the disease, Yale researchers have reported.

The surgery took place in two stages March 6-7 and the patient was discharged from Yale-New Haven Hospital March 10. The young man is the second of five patients who are scheduled to participate in the groundbreaking clinical trial.

"The patient is doing fine," said Timothy Vollmer, M.D., associate professor of neurology at Yale School of Medicine. "He has a high level of disability because of the location of the lesions in the brain, but he is otherwise healthy."

There are an estimated 1.4 million persons worldwide with multiple sclerosis. The young man in the trial suffers from a relapsing form of multiple sclerosis, which Vollmer said is the most common form of multiple sclerosis. It affects three times as many women as men.

Vollmer said he and his team hope to perform the procedure on a third patient next month.

The purpose of the Phase One trial is to determine whether cells found in the bodys peripheral nerves, in this case, the ankle, can safely repair the damaged cells in the brain and spinal cord that result in neurologic disability in patients with multiple sclerosis and other disorders of myelin.

In multiple sclerosis, the immune system attacks the brains nerve fibers and strips away the protective myelin sheath around nerve fibers in the spinal cord and brain. The resulting lesions make it difficult for the nerves to transmit messages.

In the first procedure on March 6, the surgical team harvested Schwann cells from the patients ankle. Animal studies show that Schwann cells can replace the cells that generate the myelin. The second day, the cells were injected into the left posterior aspect of the patients brain, which has lesi
'"/>

Contact: Jscqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
14-Mar-2002


Page: 1 2

Related medicine news :

1. Secondhand smoke linked to cervical cancer
2. Second NIAID SARS vaccine candidate helps mice fend off SARS
3. Secondhand smoke impairs lung function in women
4. Second stage of HIV vaccine trial begins in London and Oxford, UK
5. Cholesterol Carriers Better Predictors Than Cholesterol For Second Heart Attack
6. Second Annual AIDS Vaccine Day Honors Volunteers Nationwide
7. Patients Treated Successfully For Hodgkins Disease Are At 9 Times The Risk For Developing Second Cancer
8. Cedars-Sinai Medical Centers Prenatal Program Pushes the Frontiers of Diagnosis From the Second Trimester Into the First
9. AAPS Sponsors Second Frontier Symposium
10. Drug Combination Including New "Super Aspirin" Drug Cuts Risk Of Death Or Second Heart Attack
11. Drugs Effect On Chromosomes May Explain Second Cancers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... 06, 2016 , ... 'Tis the season for family, festivity, food and fun! ... the season when eating healthy, staying active, and taking medication and doing daily foot ... do. , "Shopping trips, parties and family gatherings can take their toll on ...
(Date:12/6/2016)... , ... December 06, 2016 , ... ... , the only authorized OSHA Training Institute Education Center headquartered in Northern California, ... program focused on providing occupational safety and health training to public sector employees. ...
(Date:12/5/2016)... ... December 05, 2016 , ... Edward Buckingham MD ... the arrival of the newest Sciton laser in January 2017. The Halo is ... non-ablative and ablative wavelengths for exceptional results. Outperforming more traditional lasers, the innovative ...
(Date:12/5/2016)... ... December 05, 2016 , ... Researchers at Johns Hopkins ... growing brains of young athletes. Over the course of three years, researchers will study ... mouth guards. The mouth guards, equipped with special sensors, will track the location and ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... provide alerting technology to Central Illinois Health Information Exchange (CIHIE) using its ... funds as the sole sub-recipient participating with the Illinois Health Information Exchange ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Dec. 5, 2016 Spain Glaucoma Surgery Devices ... report, "Spain Glaucoma Surgery Devices Market Outlook to 2022", ... Devices market. The report provides value, in millions of ... within market segements - Canaloplasty Micro Catheters and Glaucoma ... and distribution shares data for each of these market ...
(Date:12/5/2016)... Calif. , Dec. 5, 2016 Sangamo BioSciences, ... genome editing, announced the presentation of preclinical and manufacturing data ... at the 58 th Annual Meeting of the American ... Diego, CA , from December 3-6, 2016. ... of hemophilia A which we believe is highly competitive, and ...
(Date:12/5/2016)... 2016  Cornerstone Pharmaceuticals, Inc., a privately held, ... two Phase I trials evaluating its lead compound, ... meeting of the American Society of Hematology (ASH) ... The two datasets show encouraging efficacy and safety ... and T-cell non-Hodgkin,s lymphoma (T-cell NHL), respectively, supporting ...
Breaking Medicine Technology:
Cached News: